HRA Pharma

21 articles about HRA Pharma

• 

  HRA Pharma Seeks Approval for OTC Birth Control as Biden Mulls Emergency Action

  7/11/2022

  HRA Pharma, a Perrigo company, has submitted an application to the FDA seeking approval for the country’s first-ever over-the-counter (OTC) birth control pill.
• 

  BioSpace Global Roundup, Nov. 12

  11/12/2020

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

• AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases

  10/29/2020

  FDA-approved prescription drugs Lysodren® and Metopirone® in the United States

• HRA Pharma boosts revenues by 20.8% in 2019

  3/15/2020

  Consumer healthcare company HRA Pharma grew their total group revenues by 20.8% in 2019 with EBITDA growing by 30%

• 

  BioSpace Global Roundup, Jan. 30

  1/30/2020

  Pharma companies from across the globe provide updates on their pipelines and business.

• HRA Pharma Announces International Expansion

  12/17/2019

  Consumer healthcare company HRA Pharma will be expanding internationally into the Middle East, with the UAE and Kuwait being the first movers with the iconic footcare care brand Compeed®.

• HRA Pharma Receives ISO-13485 Certification

  11/12/2019

  The ISO 13485 audit is an essential qualification for medical device manufacturers, showing HRA Pharma’s commitment to the highest quality standard.

• HRA Pharma And Afaxys Pharmaceuticals Join Forces On Emergency Contraceptive ella® In The U.S.A .

  3/31/2014

• Morning-After Pill May Not Work For Overweight Women, HRA Pharma Reveals

  11/26/2013

• HRA Pharma and Hyundai Pharm First Launch of ellaOne(R) in Asia

  9/20/2011

• HRA Pharma Welcomes the Launch of Norlevo(R) as the First Emergency Contraceptive Pill to Become Available in Japan

  5/25/2011

• ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for Ulipristal Acetate to Treat Uterine Fibroids in Japan

  5/20/2011

• ASKA Pharmaceutical and HRA Pharma Announce Exclusive Licensing Agreement for ellaOne(R) in Japan

  5/19/2011

• FDA Advisory Committee Unanimously Recommends Approval of HRA Pharma's Ulipristal Acetate for Emergency Contraception

  6/18/2010

• New HRA Pharma "Morning-After" Pill Effective, Safe Say FDA Staff

  6/15/2010

• FDA Panel to Mull HRA Pharma's New 'Morning-After Pill' Effective After 5 Days After Sex

  6/9/2010

• Morning-after Pill From HRA Pharma Works Five Days Later

  1/29/2010

• New 'Morning-After' Pill From HRA Pharma Works for Five Days

  1/22/2010

• HRA Pharma Launches ellaOne(R) in Europe

  10/1/2009

• HRA Pharma Invest an Additional € 2.5 Million In Cell Therapy Through Its Subsidiary Celogos

  2/28/2007